Published on : Apr 17, 2018
Albany, New York, April 17, 2018: Market Research Hub (MRH) has worked to investigate into the Personalized Medicine, Targeted Therapeutics and Companion Diagnostic sector. The primary aim of this investigation is to decode the overall market which comprises of therapies and diagnosis methods for a variety of diseases hampering human health all around the globe. This research report included to the wide online repository of MRH is titled “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment”, which discourses the current as well as future market scenario until 2021.
The initial section of the report talks about the executive summary and objectives which define the actual motive of this analysis. This research report focuses on the global & USA market in specific; the prime market regions targeted in this assessment are UK, France, Germany, Italy and Spain. Furthermore, the EU region as a whole is also judiciously studied and concluded in this report. Key findings and observations useful for the readers includes knowledge about KRAS Mutations, CYP2C9 and VKORC1 mutations and Warfarin Response, New Business Model Required for Personalized Medicine, Oncotype Dx Test etc. The following section of the report highlights difference between Genotype and Phenotype, Insights about Pharmacogenetics and Introduction to Personalized Medicine.
The following report section discusses the primary segments, namely, Targeted therapeutics, Companion Diagnostics, Liquid Biopsies. Considering the sub-market analysis, companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy, are mentioned as the prime divisions. On the basis of therapy, the overall market for personalized medicine, targeted therapeutics and companion diagnostic is categorized into cancer, infectious disease and cardiovascular. The report includes some useful and resourceful data sections such as private and public funding and personalized medicine reimbursement, business model analysis and main industry players.
For the various market players, vital details such as company financials, sales & revenue figures are presented. Moreover, business model strategies for diagnostic, pharmaceutical and biotechnology companies can be accessed from this research report. Market essentials like key strengths, threats and weaknesses influencing the status of leading players in the market is also present. Furthermore, FDA Advances in Personalized Medicine Regulation, Comprehensive product portfolios, R&D activity and pipeline therapeutics etc., are debated quite wonderfully in this research. Some of the major companies examined in this report are 23andMe, Abbott Molecular Inc., Abbott Laboratories, Admera Health (GENEWIZ), Agendia, Alere, Amgen, Affymetrix, Astex Pharmaceuticals, Atossa Genetics, AstraZeneca, bioMerieux, Becton Dickenson and BristolMyersSquibb.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1714465
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org